Next Article in Journal
Consensus Recommendations for Optimizing Biomarker Testing to Identify and Treat Advanced EGFR-Mutated Non-Small-Cell Lung Cancer
Previous Article in Journal
The Cost of Failed First-Line Cancer Treatment Related to Continued Smoking in Canada
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Perspectives of Hematology Oncology Clinicians about Integrating Palliative Care in Oncology

1
Department of Psychosocial Oncology, Tom Baker Cancer Centre, Calgary, Holy Cross Site, 2210–2 Street SW, Calgary, AB T2S 3C3, Canada
2
Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
3
Department of Oncology, University of Calgary, Calgary, AB, Canada
4
Department of Family Medicine, University of Calgary, Calgary, AB, Canada
5
Department of Medicine, University of Calgary, Calgary, AB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2020, 27(6), 313-320; https://doi.org/10.3747/co.27.6305
Submission received: 9 September 2020 / Revised: 7 October 2020 / Accepted: 11 November 2020 / Published: 1 December 2020

Abstract

Patients with hematologic malignancies receive palliative care (PC) less frequently and later than patients with solid tumours. We compared survey responses of hematology oncology clinicians with other oncology clinicians to better understand their challenges with providing primary PC or using secondary PC. Patients’ negative perceptions of PC and limited time or competing priorities were challenges for all clinicians. Compared with other oncology clinicians, more hematology oncology clinicians perceived PC referral criteria as too restrictive (40% vs. 22%, p = 0.021) and anticipated that integrating pc supports into their practice would require substantial change (53% vs. 28%, p = 0.014). This study highlights barriers that may need targeted interventions to better integrate pc into the care of patients with hematologic malignancies.
Keywords: hematologic malignancies; clinician perspectives; mixed-methods hematologic malignancies; clinician perspectives; mixed-methods

Share and Cite

MDPI and ACS Style

Booker, R.; Dunn, S.; Earp, M.A.; Sinnarajah, A.; Biondo, P.D.; Simon, J.E. Perspectives of Hematology Oncology Clinicians about Integrating Palliative Care in Oncology. Curr. Oncol. 2020, 27, 313-320. https://doi.org/10.3747/co.27.6305

AMA Style

Booker R, Dunn S, Earp MA, Sinnarajah A, Biondo PD, Simon JE. Perspectives of Hematology Oncology Clinicians about Integrating Palliative Care in Oncology. Current Oncology. 2020; 27(6):313-320. https://doi.org/10.3747/co.27.6305

Chicago/Turabian Style

Booker, R., S. Dunn, M.A. Earp, A. Sinnarajah, P.D. Biondo, and J.E. Simon. 2020. "Perspectives of Hematology Oncology Clinicians about Integrating Palliative Care in Oncology" Current Oncology 27, no. 6: 313-320. https://doi.org/10.3747/co.27.6305

Article Metrics

Back to TopTop